Member Info for Jace86

I think the MOU is better.

Royalty goes from 15 to 10 percent.

But we are guaranteed some income. Previously we wasn't.

If income exceeds what we are guaranteed we then get that.

We get 10 percent of BIO. If BIO really does well, then eventually lists that alone could propel our value to pounds. Think of how pharma firms go on NASDAQ...

I don't think it needs to. You can't have an MOU unless there is something for multiple parties to agree on.

Fwiw I do think the asset is extremely valuable and has major potential.

Sorry, yes I don't know why I wrote 6 months earlier. It is 4.

I do wonder if Mr Miller has any inside track whatsoever or is he like us, remaining in the dark?

The price would be helped by preventing the market from needing to make assumptions on progress.

The last six months lead to this with the RNS "engaging clinical design" to only lead to what we now know.

Whilst it may very well be the case that we know how things will be structured, a lot was expecting significant news to due to the length of time that we waited.

Let's hope that "finalising binding agreement" doesn't necessarily take the full 6 months.

This again an assumption that BIO have paid. We simply don't know. Again.

Daddylonglegs - they had to issue an RNS recently on share capital. They should have done this immediately after the placing shares hit the market.

Ok unblocked.

I see we are on the same page with this.

The reply to Joe blogs was unacceptable. His job is to find out and encourage it.

If anyone has it, email Allan directly and point him to the reply from Tim and the view from Allenby.

Is it alive or dead.

The company needs to open the box...

It cannot be had both ways where it is sensitive and we cannot be told or that it doesn't warrant an announcement. It's one or the other.

It is material.

It would also mean that investors aren't holding on for another 6 months to make assumptions about the direction.

They'll should be told.

Tim should be encouraging the company. It's PR and essential.

The news in either direction has a material impact on price.

We've said we expect it. If we don't have what we expect then people make a decision to buy or sell. It's material.

I think Joe might have lost his twitter account recently so he's back to trolling here...

Technically still until Monday. If it comes in later via the US tomorrow might not RNS until Monday (if they decide to - and they should)

It is price sensitive news. It ultimately tells the market if the MOU is alive or not.

It should be RNSd.

I see that your keyboard disappeared too after the first few words 😂

Will that jab cure it?

Lots of questions surrounding it.

I wouldn't take it.

Remember the covid jabs they issued. They guaranteed all sorts and claims of 100% effecacy kept on coming down and down to now people absconding of their advice to take it because of long term complications.

Will that

That was my thoughts LB. I do wonder if we have holders being deducted or included in nominee accounts as per my post yesterday...

No Hog - it wasn't needed. Its a funny one.

I do wonder if the company is reaching out to update the shareholders register.

I also wonder if some of these large holders also hold on platforms that have reportable holdings and someone does the math if they are to update.

That's correct, we don't actually know when he got them and can only assume unless someone knows him or he could say on here.

Your calcs (not calls) - I hate autocorrect

Hi Daz - your calls omit the other raises we've had between the events noted by Cymru.

If you can backtrack to previous totals for shares in issue you might be able to see what was in issue exactly in Sept 22.